Review of New Generation Neuroleptics in the Treatment of Psychosis
DOI:
https://doi.org/10.51699/ijhsms.v2i6.2149Abstract
Antipsychotics are drugs that restore dopamine imbalance in the mesocortical, mesolimbic, nigrostriatal and tuberoinfundibular pathways of the brain, causing psychotic states. For this reason, drugs in this group are also called antipsychotics. Antipsychotics act on the dopaminergic system in such a way that they eliminate psychotic symptoms - first of all, perceptual delusions (auditory, visual, tactile hallucinations), delirium and psychomotor agitation.
Downloads
References
Geddes J., Freemantle N., Harrison P., Bebbington P. "Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis".
Jindal RD, Keshavan MS “Classifying antipsychotic agents. Need for new terminology.
Correll CU, Rubio JM, Inczedy-Farkas G. "Efficacy of 42 pharmacological cotreatment strategies added to antipsychotic monotherapy in schizophrenia
Wang SM, Han C., Lee SJ "Investigational dopamine antagonists for the treatment of schizophrenia".
K.S. Raevsky. "Modern Antipsychotics: Interactions with Brain Neurotransmitter Systems".
Mosolov S. N. Modern antipsychotic pharmacotherapy of schizophrenia // Neurology. Psychiatry. - May 29, 2004. - No. 10. Archived March 3, 2012.
Danilov D.S. Classifications of antipsychotics and their significance for the choice of therapy for schizophrenia (to the 60th anniversary of the advent of neuroleptics) // Journal of Neurology and Psychiatry. S. S. Korsakov. - 2011. - No. 10. - S. 91-100.
Mashkovsky, M. D. Antipsychotics // Medicines. - 15th ed. - M .: New Wave, 2005. - 1200 p. — ISBN 5-7864-0203-7.
